Target intelligence / Profile preview

Proline and serine-rich protein 2 (PROSER2)

Target
PROSER2
Molecular classification
Other (Uncharacterized protein)
01

Overview

Proline and serine-rich protein 2 (PROSER2) is an uncharacterized protein encoded by the PROSER2 gene, also known as C10orf47, located at chromosome 10p14. Recent research has identified PROSER2 as a membrane- and cytosol-localized protein; its expression is higher in primary tumor tissues than in metastases for pancreatic ductal adenocarcinoma (PDAC). In functional assays, overexpression of PROSER2 suppressed the invasion and proliferation of cancer cells, while knockdown promoted these processes, suggesting a role in maintaining a less aggressive tumor phenotype. PROSER2 interacts directly with the kinase STK25 and the protein PDCD10, enhancing AMP-activated protein kinase (AMPK) signaling through the STK25-AMPK pathway and contributing to its anti-invasion effects. As such, PROSER2 has been suggested as a potential prognostic marker and possible therapeutic target for certain cancers, although no validated drugs or mechanisms of pharmacological targeting exist to date. Its precise molecular function remains to be fully elucidated, but it is implicated in regulation of cell proliferation, invasion, and signaling pathways associated with tumor progression.

Other names
C10orf47MGC35403Chromosome 10 open reading frame 47proline and serine rich 2
02

Biological functions

Putative negative regulator of cell proliferation and invasion in cancerInteracts with proteins involved in cell death, differentiation, and chromatin maintenanceModulates AMP-activated protein kinase (AMPK) signaling via interaction with STK25Possible involvement in cell integrity and cell cycle progression
03

Disease associations

Cancer (notably pancreatic ductal adenocarcinoma, osteosarcoma, other cancers)Poor prognosis marker in some tumor typesPotential biomarker in various epithelial and hematological cancers
04

Biomarkers

Possible prognostic biomarker (particularly in pancreatic, bone, epithelial, and hematological cancers)

Beyond the preview

Go deeper on Proline and serine-rich protein 2 (PROSER2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Proline and serine-rich protein 2 (PROSER2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call